457 related articles for article (PubMed ID: 32701062)
21. Nomogram for prognosis of patients with esophageal squamous cell cancer after minimally invasive esophagectomy established based on non-textbook outcome.
Xu SJ; Lin LQ; Chen TY; You CX; Chen C; Chen RQ; Chen SC
Surg Endosc; 2022 Nov; 36(11):8326-8339. PubMed ID: 35556169
[TBL] [Abstract][Full Text] [Related]
22. A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.
Lin Y
BMC Surg; 2022 Jul; 22(1):256. PubMed ID: 35787802
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of treatment options and construction nomograms to predict survival for early-stage esophageal cancer: a population-based study.
Jia R; Xiao W; Zhang H; Yu Z
Scand J Gastroenterol; 2021 Jun; 56(6):635-646. PubMed ID: 33872097
[TBL] [Abstract][Full Text] [Related]
24. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
25. Construction and verification of prognostic nomogram for early-onset esophageal cancer.
Liu X; Guo W; Shi X; Ke Y; Li Y; Pan S; Jin Y; Wang Y; Ruan Q; Ma H
Bosn J Basic Med Sci; 2021 Dec; 21(6):760-772. PubMed ID: 33823125
[TBL] [Abstract][Full Text] [Related]
26. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.
Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A
Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519
[TBL] [Abstract][Full Text] [Related]
27. Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database.
Cao X; Wu B; Li H; Xiong J
Front Surg; 2023; 10():1131385. PubMed ID: 37143768
[TBL] [Abstract][Full Text] [Related]
28. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis.
Zheng Y; Fu S; He T; Yan Q; Di W; Wang J
Eur J Surg Oncol; 2018 Aug; 44(8):1199-1204. PubMed ID: 29784506
[TBL] [Abstract][Full Text] [Related]
29. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
[No Abstract] [Full Text] [Related]
30. Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma.
Kang M; Wang Y; Yang M; Wang X; Zhu L; Zhang M
Sci Rep; 2023 Mar; 13(1):4931. PubMed ID: 36967413
[TBL] [Abstract][Full Text] [Related]
31. The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
Cheng S; Yang L; Dai X; Wang J; Han X
BMC Cancer; 2021 Sep; 21(1):1057. PubMed ID: 34563149
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study.
He J; Ni JP; Li GB; Yao J; Ni B
Clin Respir J; 2023 Mar; 17(3):197-210. PubMed ID: 36718941
[TBL] [Abstract][Full Text] [Related]
33. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
[TBL] [Abstract][Full Text] [Related]
34. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
Worni M; Martin J; Gloor B; Pietrobon R; D'Amico TA; Akushevich I; Berry MF
J Am Coll Surg; 2012 Nov; 215(5):643-51. PubMed ID: 23084493
[TBL] [Abstract][Full Text] [Related]
35. Two novel clinical tools to predict the risk of bone metastasis and overall survival in esophageal cancer patients: a large population-based retrospective cohort study.
Jiang L; Tong Y; Jiang J; Zhao D
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11759-11777. PubMed ID: 37407847
[TBL] [Abstract][Full Text] [Related]
36. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
Yang M; Zhang H; Huo X; Chen C; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
[TBL] [Abstract][Full Text] [Related]
37. A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy.
Duan J; Xie Y; Qu L; Wang L; Zhou S; Wang Y; Fan Z; Yang S; Jiao S
J Immunother Cancer; 2018 Oct; 6(1):100. PubMed ID: 30285868
[TBL] [Abstract][Full Text] [Related]
38. Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma.
Merritt RE; Abdel-Rasoul M; Souza DM; Kneuertz PJ
J Surg Oncol; 2021 Mar; 123(4):881-890. PubMed ID: 33333590
[TBL] [Abstract][Full Text] [Related]
39. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
40. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
